Cat.#: ACPP-1273
| Despition | BTB/POZ domain-containing protein 7 Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1270 | Luteinizing Hormone Blocking Peptide (AC1270) | 250 µg | inquiry |
| ACPP-1421 | Human il-6 Protein, HEK (AC1421) | 2 µg | inquiry |
| ACPP-1356 | GIRK2 Blocking Peptide (AC1356) | 250 µg | inquiry |
| ACPP-1678 | Human SDCBP Protein (AC1678) | 5 µg | inquiry |
| ACPP-1199 | Beta crystallin S Blocking Peptide (AC1199) | 250 µg | inquiry |
| ACPP-1194 | Calcium Sensing Receptor Blocking Peptide (AC1194) | 250 µg | inquiry |
| ACPP-1180 | Native Human Luteinizing Hormone (Functional) (AC1180) | 100 µg | inquiry |
| ACPP-1167 | Recombinant Human CD133 Protein (Fc Tag) (AC1167) | 50 µg | inquiry |
| ACPP-1085 | Recombinant Human alpha Internexin Protein (AC1085) | 25 µl | inquiry |
| ACPP-1264 | SorLA Blocking Peptide (AC1264) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.